Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cascadia microbes 2022 season

ABSTRACT: Cascadia 2022

PROVIDER: PRJEB75651 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR13150900_1.fastq.gz	Fastqsanger.gz
	ERR13150900_2.fastq.gz	Fastqsanger.gz
	ERR13151000_1.fastq.gz	Fastqsanger.gz
	ERR13151000_2.fastq.gz	Fastqsanger.gz
	ERR13151100_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1582

Similar Datasets

Influenza season 2022-2023 Oxford sequencing

Project description:Influenza season 2022-2023 Oxford sequencing

| PRJEB56915 | ENA

Virological characterization of the 2022 outbreak-causing monkeypox virus using human keratinocytes and colon organoids

Project description:The outbreak-causing monkeypox virus of 2022 (2022 MPXV) is classified as a clade IIb strain and phylogenetically distinct from prior endemic MPXV strains (clades I or IIa), suggesting that its virological properties may also differ. Here, we used human keratinocytes and induced pluripotent stem cell-derived colon organoids to examine the efficiency of viral growth in these cells and the MPXV infection-mediated host responses. MPXV replication was much more productive in keratinocytes than in colon organoids. We observed that MPXV infections, regardless of strain, caused cellular dysfunction and mitochondrial damage in keratinocytes. Notably, a significant increase in the expression of hypoxia-related genes was observed specifically in 2022 MPXV-infected keratinocytes. Our comparison of virological features between 2022 MPXV and prior endemic MPXV strains revealed signaling pathways potentially involved with the cellular damages caused by MPXV infections and highlights host vulnerabilities that could be utilized as protective therapeutic strategies against human mpox in the future.

2023-06-06 | GSE219036 | GEO

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022

Project description:The World Health Organization Classification of Hematolymphoid Tumors (WHO) and the International Consensus Classification (ICC) of 2022 introduced major changes to the definition of CMML. To assess qualitative and quantitative implications for patient care, we started with 3,311 established CMML cases (according to WHO 2017 criteria) and included also 2,130 oligomonocytosis cases fulfilling the new CMML diagnostic criteria. Applying both classification systems from 2022, 356 and 241 of oligomonocytosis cases were newly classified as myelodysplastic (MD)-CMML (WHO and ICC 2022, respectively), most of which were diagnosed as MDS according to WHO 2017. Importantly, 1.5 times more oligomonocytosis cases were classified as CMML according to WHO 2022 than based on ICC, due to different diagnostic criteria. Genetic analyses of the newly classified CMML cases showed a distinct mutational profile with strong enrichment of MDS-typical alterations, resulting in a transcriptional subgroup separated from established MD- and myeloproliferative (MP)-CMML. Despite a different cytogenetic, molecular, immunophenotypic, and transcriptional landscape, no differences in overall survival were found between newly classified and established MD-CMML cases. To the best of our knowledge, this study represents the most comprehensive analysis of routine CMML cases to date, both in terms of clinical characterization and transcriptomic analysis, placing newly classified CMML cases on a disease continuum between MDS and previously established CMML.

2023-12-07 | GSE249547 | GEO

Mycobacterium marinum strain:487-2022 | isolate:487-2022

Project description:Mycobacterium marinum strain:487-2022 | isolate:487-2022 Assembly

| PRJNA1234038 | ENA

Matsu(2021-2022)

Project description:Matsu(2021-2022) Metagenome

| PRJNA1061338 | ENA

Populus trichocarpa cultivar:2022

Project description:Populus trichocarpa 2022 Resequencing

| PRJNA501249 | ENA

Srikant et al. 2022

Project description:Srikant et al. 2022

| PRJEB53879 | ENA

The 2022 West Nile Virus Season in Greece; A Quite Intense Season.

Project description:Since 2010, the West Nile virus (WNV) has been established in Greece. We describe the epidemiology of diagnosed human WNV infections in Greece with a focus on the 2022 season. During the transmission period, clinicians were sending samples from suspected cases for testing. Active laboratory-based surveillance was performed with immediate notification of diagnosed cases. We collected clinical information and interviewed patients on a timely basis to identify their place of exposure. Besides serological and molecular diagnostic methods, next-generation sequencing was also performed. In 2022, 286 cases of WNV infection were diagnosed, including 278 symptomatic cases and 184 (64%) cases with neuroinvasive disease (WNND); 33 patients died. This was the third most intense season concerning the number of WNND cases, following 2018 and 2010. Most (96%) cases were recorded in two regions, in northern and central Greece. The virus strain was a variant of previous years, clustering into the Central European subclade of WNV lineage 2. The 2022 WNV season was quite intense in Greece. The prompt diagnosis and investigation of cases are considered pivotal for the timely response, while the availability of whole genome sequences enables studies on the molecular epidemiology of the disease.

| S-EPMC10383024 | biostudies-literature

Schizosaccharomyces sp. A1 LZ-2022 isolate:A1 LZ-2022

Project description:Schizosaccharomyces sp. A1 LZ-2022 isolate:A1 LZ-2022 Genome sequencing and assembly

| PRJNA871051 | ENA

LEAP 2022 Bacterioplankton

Project description:LEAP 2022 Bacterioplankton Raw sequence reads

| PRJNA1277156 | ENA